NCT02099669.

Methods	RCT (feasibility) (Canada)
Participants	All participants with MDS ≥ 18 years of age, transfusion dependent: at least 1 transfusion per month in the last 8 weeks, haemoglobin < 10 g/dL
Interventions	Liberal transfusion strategy: to maintain Hb between 11 g/dL and 12 g/dL Restrictive transfusion strategy: to maintain Hb between 8.5 g/dL and 10 g/dL
Outcomes	Percentage compliance
Notes	Trial registration (prospective): NCT02099669

Abbreviations

Hb: haemoglobin concentration
MDS: myelodysplastic syndrome
RCT: randomised controlled trial